Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

8.64
Delayed Data
As of 4:00pm ET
 -0.17 / -1.93%
Today’s Change
7.99
Today|||52-Week Range
12.15
-7.10%
Year-to-Date
Gurus' Worst Recent Investments
Feb 15 / GuruFocus News - Paid Partner Content
Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017
Feb 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close8.81
Today’s open8.87
Day’s range8.63 - 8.92
Volume3,845,736
Average volume (3 months)4,335,548
Market cap$4.9B
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-16.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratioNM
Price/Sales9.97
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-1.50-1.29%
ACADACADIA Pharmaceutica...-0.08-0.20%
PTHNPatheon NV+0.43+1.37%
GRFSGrifols SA+0.07+0.40%
Data as of 4:03pm ET, 02/21/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts


Search for Jobs